• About
  • Masthead
  • License Content
  • Advertise
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Oncology

Study examines parental hope in childhood advanced cancer

byPuja UmaretiyaandCordelia Ross
April 13, 2015
in Oncology, Pediatrics
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. In this study examining conversations between parents and physicians regarding prognosis of children with advanced cancer, most physicians communicated at least 1 statement about the child’s prognosis, though 25% used nonspecific statements. None of these physicians asked parents about their hopes.

2. The majority of parents expressed a hope for a cure, while recognizing that this was contradictory to their expectations of the prognosis. When asked for other hopes, many stated quality of life and minimal suffering.

Study Rundown: Though parents of children with cancer continue to have hope, little is known about the nature of that hope and whether parents are able to reconcile hope with a poor prognosis. This study recorded conversations that took place between physicians and parents of children with advanced cancer. Interviews were also recorded with parents about their hopes to characterize and better understand parental hope. Most physicians communicated at least 1 statement about the child’s prognosis and presented treatment options. A little over half expressed their own hopes, while none asked the parents about their hopes. While the majority of parents continued to hope for a cure, almost 75% of these parents also realized that their hopes contradicted their expectations of the prognosis. This study is limited by generalizability, as the majority of participants were white and non-English speaking parents were excluded. However, this study highlights that physicians may be able enhance end-of-life care for children with advanced cancer by asking parents about their hopes, recognizing that many parents understand that some hopes may be incongruent with their expectations.

Click to read the study, published in Pediatrics

Relevant Reading: The breadth of hopes.

In-Depth [cross-sectional study]: Participants were 32 parents of children with newly recurrent or refractory advanced cancer and their physicians. Physician-parent conversations took place from February 2010 to October 2013 at the Dana-Farber Cancer Institute and Boston Children’s Hospital. Children of participants were a median of 10.1 years old; 56% had a solid tumor diagnosis, 38% had a brain tumor, and 6% had a hematologic malignancy. Eighty-one percent of participating parents were female, and 75% were white. Over half of the children (56%) were present during the entire physician-parent conversation. While physicians in 28/32 (88%) conversations included statements about the child’s prognosis, 8 conversations included only nonspecific statements as the sole prognostic statement. Almost all (90%) of the physicians included treatment options in the conversation. More than half of the physicians stated their own hopes (56%), but none of the physicians directly asked parents about their hopes. In the post-interview follow-up with study personnel, parents expressed expectations that were similar to what their physicians had stated about prognosis. However, most (88%) still expressed a hope that their child would be cured. Other hopes included quality of life (90%), minimal suffering (75%), and future research/better treatment of children in the future (25%). Most parents (72%) recognized that their hopes were incongruent from their expectations of the outcome for their child.

RELATED REPORTS

Artificial intelligence capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cancerchildhood cancer
Previous Post

Hematopoietic stem-cell transplantation may increase risk of fractures

Next Post

Exposure to alcohol in movies linked to drinking among teens

RelatedReports

An illustration featuring a stomach, DNA helix, and a close-up of Helicobacter pylori bacteria, highlighting genetic susceptibility to gastric conditions.
Artificial Intelligence

Artificial intelligence capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

October 16, 2026
A collage illustrating the urinary bladder, immune system elements, cancer cells, and an IV bag, highlighting immunotherapy for urothelial cancer.
Chronic Disease

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

September 22, 2026
An illustration featuring blood cells and a vial with pills, representing hemophilia and potential treatments for blood coagulation.
Cardiology

Borderline-low hemoglobin levels linked to increased mortality

September 14, 2026
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Artificial Intelligence

The Scan by 2 Minute Medicine®: Susie Wiles breast cancer diagnosis drives national screening surge, Jensen Huang’s GTC keynote turns healthcare AI into a pop-culture phenomenon, landmark ACSM guidelines simplify resistance training for longevity, and consumer alert issued for high-pressure cosmetic surgery chains

March 25, 2026
Next Post
Exposure to maternal depression linked to adolescent risk behaviors

Exposure to alcohol in movies linked to drinking among teens

Updated USPSTF guidelines favor treatment of mild gestational diabetes

USPSTF finds insufficient evidence for improved mortality from diabetes screening

Medicare beneficiaries have a lower rate of delayed melanoma surgeries

Medicare beneficiaries have a lower rate of delayed melanoma surgeries

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • A community health initiative in low-income areas may reduce hospital admission rates
  • Induction with remimazolam (Byfavo) for patients undergoing laparoscopic gastrointestinal surgery may reduce post-operative delirium compared with propofol
  • 2 Minute Medicine Rewind October 19, 2026
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.